Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Yesterday, Lilly held the official opening of its...
Jiangsu Hengrui Medicine has in-licensed China rights to...
Golden Meditech, a Beijing medical device company, will...
Chindex accepted a buy-out offer of $24 per share from...
Jiangsu Hengrui Medicine received CFDA permission to...
Shenzhen Hepalink Pharma, a heparin API company, will...
Jiangsu Hengrui Medicine announced plans to spend $137...
Jiangsu Hengrui Medicine will invest $240 million to...
MabSpace Biosciences, a Suzhou antibody company, raised...
Jiangsu Hansoh Pharma is planning a $3 billion Hong Kong...
Upcoming Events
BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here
Register here
Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events
Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here